Cedarburg Hauser Upgrades API Manufacturing Plant
News Sep 26, 2013
Cedarburg Hauser Pharmaceuticals (CHP) has announced the improvement of its Active Pharmaceutical Ingredient (API) plant in Grafton, WI.
These upgrades are a continuation of a long-term capital improvement initiative that results from an increased demand for the contract manufacturing of commercial APIs.
“Our customer’s demand for Cedarburg Hauser commercial APIs continues to grow; upgrading our facilities are a must as we grow with our customers” stated Cedarburg Hauser CEO Tony Laughrey. “We will continue to upgrade and expand our facilities, ensuring supply for our customers.”
The upgraded facilities are expected to facilitate in a 20-25% increase in API production. Improvements to the plant include the addition of a 30 ton process chiller, an additional 200 kilowatt backup generator and an industrial vacuum pump. CHP has also tripled its filtration capacity through the addition of new, large Aurora Filters.
“The upgrades to our manufacturing facility are all about operational efficiency” says John Flahive, Director of Operations.
Flahive continued, “With these improvements we are able to increase our functional capacity by approximately 20%, allowing us to produce more material in a shorter amount of time for our clients.”
Cell Recycling System Offers Therapeutic Entry Point for Rare Disease TreatmentNews
Scientists have demonstrated how an investigational drug works against a rare, fatal genetic disease, Niemann-Pick type C1 (NPC1).READ MORE
Cancer Cells Force Normal Cells to Act Like Viruses, Helping Tumors SpreadNews
Researchers reveal how cancer cells force normal cells to act like viruses – allowing tumors to grow, resist treatment, and spread.READ MORE
Edith Heard Unanimously Selected as Next Director General of EMBLNews
At its 53rd meeting yesterday, EMBL Council selected Edith Heard as the organization’s fifth Director General. Heard’s mandate is scheduled to begin 1 January 2019.READ MORE
Comments | 0 ADD COMMENT
EMBL Conference: European Conference of Life Science Funders and Foundations
Apr 19 - Apr 20, 2018
EMBL Course: Target Engagement in Biology and Drug Discovery
Feb 19 - Feb 23, 2018